Fidelity Investments
BBNX

Fidelity Investments’s Beta Bionics BBNX Stock Holding History

Fidelity Investments’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55K Buy
3,512
+313
+10% +$3.72K ﹤0.01% 4269
2026
Q1 		$32.1K Sell
3,199
-13,912
-81% -$206K ﹤0.01% 4314
2025
Q4 		$521K Buy
17,111
+301
+2% +$8.04K ﹤0.01% 3074
2025
Q3 		$334K Buy
16,810
+433
+3% +$7.61K ﹤0.01% 3183
2025
Q2 		$238K Buy
16,377
+9,494
+138% +$134K ﹤0.01% 3243
2025
Q1 		$84.2K Buy
+6,883
New +$128K ﹤0.01% 3633

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Fidelity Investments's BBNX Position: Q2 2026 in Review

Fidelity Investments increased its Beta Bionics (BBNX) stake by 9.8% in Q2 2026, buying an estimated $3.72K and bringing the position to 3,512 shares worth $55K. The position accounts for ﹤0.01% of the portfolio, ranked #4269.

Fidelity Investments first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $521K in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Fidelity Investments held 3,512 shares of Beta Bionics worth $55K as of Q2 2026.
  • Fidelity Investments bought 313 Beta Bionics shares in Q2 2026, an estimated $3.72K.
  • Beta Bionics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4269 holding.
  • Fidelity Investments first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • Fidelity Investments's Beta Bionics position peaked at $521K in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.